T1	Participants 78 140	patients with diffuse peritonitis at the postoperative period]
T2	Participants 176 187	64 patients
T3	Participants 199 319	that inclusion of complex antioxidant cytoflavin in intensive therapy at the postoperative period of diffuse peritonitis
